相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cascade-responsive nano-assembly for efficient photothermal-chemo synergistic inhibition of tumor metastasis by targeting cancer stem cells
Xianqi Zhu et al.
BIOMATERIALS (2022)
Homotypic biomimetic coating synergizes chemo-photothermal combination therapy to treat breast cancer overcoming drug resistance
Kai Guo et al.
CHEMICAL ENGINEERING JOURNAL (2022)
Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy
Xuanhua P. Xie et al.
DEVELOPMENTAL CELL (2022)
Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes
Jun-yi Zhu et al.
DISEASE MODELS & MECHANISMS (2022)
GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance
Yang Liping et al.
DRUG DELIVERY (2022)
Stimuli-responsive charge-reversal MOF@polymer hybrid nanocomposites for enhanced co-delivery of chemotherapeutics towards combination therapy of multidrug-resistant cancer
Liefeng Hu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)
Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy
Yu Geng et al.
JOURNAL OF CONTROLLED RELEASE (2022)
A self-amplified ROS-responsive chemodrug-inhibitor conjugate for multi-drug resistance tumor therapy
Tingting Sun et al.
BIOMATERIALS SCIENCE (2022)
Synergistic antitumor efficacy of PD-1-conjugated PTX-and ZSQ-loaded nanoliposomes against multidrug-resistant liver cancers
Mingjia Gu et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)
3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs
Melanie A. G. Barbosa et al.
CANCERS (2022)
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer
Yufan Guo et al.
PHARMACEUTICS (2022)
Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance
Lipeng Qiu et al.
ACTA BIOMATERIALIA (2022)
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Bradley I. Reinfeld et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells
Ke Liu et al.
CELL DEATH & DISEASE (2022)
Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer
Xiangyang Zhang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Matrix Metalloproteinase-2-Responsive Surface-Changeable Liposomes Decorated by Multifunctional Peptides to Overcome the Drug Resistance of Triple-Negative Breast Cancer through Enhanced Targeting and Penetrability
Changliang Liu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)
Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppression
Hui Peng et al.
CARBOHYDRATE POLYMERS (2022)
DNA damage and metabolic mechanisms of cancer drug resistance
Deanna Tiek et al.
CANCER DRUG RESISTANCE (2022)
FDG PET correlates weakly with HIF-1α expression in solid tumors: a meta-analysis
Alexey Surov et al.
ACTA RADIOLOGICA (2021)
Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
Mohammad Reza Karimzadeh et al.
CANCER GENE THERAPY (2021)
Advances in nanomaterials for treatment of hypoxic tumor
Mei-Zhen Zou et al.
NATIONAL SCIENCE REVIEW (2021)
Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells
Zhaoshi Bai et al.
CELL BIOLOGY INTERNATIONAL (2021)
Co-administration of paclitaxel and 2-methoxyestradiol using folate-conjugated human serum albumin nanoparticles for improving drug resistance and antitumor efficacy
Xinyang Liu et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2021)
Acidic microenvironment enhances MT1-MMP-mediated cancer cell motility through integrin β1/cofilin/F-actin axis
Lubiao Liang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy
Wen-Jun Wan et al.
ACTA BIOMATERIALIA (2021)
Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy
Lian-Hua Fu et al.
ADVANCED MATERIALS (2021)
Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal
Xuan Xiao et al.
BIOMATERIALS (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Redox-responsive polyethyleneimine/tetrahedron DNA/doxorubicin nanocomplexes for deep cell/tissue penetration to overcome multidrug resistance
Jianqin Yan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
Xiaobin Zeng et al.
PHARMACOLOGICAL RESEARCH (2021)
Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer
Martina Di Francesco et al.
ACS OMEGA (2021)
A Near-Infrared-II Polymer with Tandem Fluorophores Demonstrates Superior Biodegradability for Simultaneous Drug Tracking and Treatment Efficacy Feedback
Dengshuai Wei et al.
ACS NANO (2021)
Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter
Shivendra Vikram Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer
Xiaoqun Shi et al.
CARBOHYDRATE POLYMERS (2021)
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
Courtney L. Jones et al.
CELL STEM CELL (2021)
Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance
Hongzhi Wang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Co-delivery of cisplatin and oleanolic acid by silica nanoparticles-enhanced apoptosis and reverse multidrug resistance in lung cancer
Xiao-Kai Zhang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2021)
Hyaluronic acid (HA)-coated naproxen-nanoparticles selectively target breast cancer stem cells through COX-independent pathways
Eva Espinosa-Cano et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles
Sadaf Mushtaq et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2021)
Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells
Saul A. Navarro-Marchal et al.
BIOMACROMOLECULES (2021)
A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway
Xueqin Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Metabolic adaptation in hypoxia and cancer
Felipe Paredes et al.
CANCER LETTERS (2021)
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis
Lorena Simon-Gracia et al.
NANOMATERIALS (2021)
Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells
Weinan Li et al.
FRONTIERS IN ONCOLOGY (2021)
Resveratrol-Loaded TPGS-Resveratrol-Solid Lipid Nanoparticles for Multidrug-Resistant Therapy of Breast Cancer: In Vivo and In Vitro Study
Wenrui Wang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
The hallmarks of ovarian cancer stem cells and niches: Exploring their harmonious interplay in therapy resistance
Takeshi Motohara et al.
SEMINARS IN CANCER BIOLOGY (2021)
Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance
Emily L. Giddings et al.
NATURE COMMUNICATIONS (2021)
Effects of the surface charge of polyamidoamine dendrimers on cellular exocytosis and the exocytosis mechanism in multidrug-resistant breast cancer cells
Jie Zhang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Glutathione-Activated NO-/ROS-Generation Nanoparticles to Modulate the Tumor Hypoxic Microenvironment for Enhancing the Effect of HIFU-Combined Chemotherapy
Qianyan Li et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma
Zijing Du et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA
Ye Yuan et al.
ACTA BIOMATERIALIA (2021)
Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal
Qingyu Zong et al.
BIOMATERIALS (2021)
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su et al.
DRUG RESISTANCE UPDATES (2021)
TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer
Kaipei Luo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
In-vitro tumor microenvironment models containing physical and biological barriers for modelling multidrug resistance mechanisms and multidrug delivery strategies
Mehdi Rahmanian et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells
Bruna Stefane Alves de Oliveira et al.
LIFE SCIENCES (2021)
Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
Donghui Gan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances
Yavuz Nuri Ertas et al.
NANOMATERIALS (2021)
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou et al.
CANCERS (2021)
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Yongmei Zhao et al.
PHARMACEUTICS (2021)
Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
Muhammad Nadeem Hafeez et al.
PROCESSES (2021)
Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma
Yi Gao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas et al.
NANOSCALE RESEARCH LETTERS (2021)
Cancer models in preclinical research: A chronicle review of advancement in effective cancer research
Humna Sajjad et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2021)
CD133 peptide-conjugated pyropheophorbide-a as a novel photosensitizer for targeted photodynamic therapy in colorectal cancer stem cells
Shichao Yan et al.
BIOMATERIALS SCIENCE (2021)
Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol
Christian Celia et al.
ADVANCED THERAPEUTICS (2021)
Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions
A. Tolios et al.
DRUG RESISTANCE UPDATES (2020)
ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer
Wen Wu et al.
ACTA BIOMATERIALIA (2020)
Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer
Shuguang Wei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Ultrasmall platinum nanoparticles enable deep tumor penetration and synergistic therapeutic abilities through free radical species-assisted catalysis to combat cancer multidrug resistance
Ranjith Kumar Kankala et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Advanced technological tools to study multidrug resistance in cancer
Luca Andrei et al.
DRUG RESISTANCE UPDATES (2020)
Folate-Gold-Bilirubin Nanoconjugate Induces Apoptotic Death in Multidrug-Resistant Oral Carcinoma Cells
Pierson Rathinaraj et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2020)
Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
Maryam Majidinia et al.
IUBMB LIFE (2020)
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang et al.
DRUG RESISTANCE UPDATES (2020)
Nanomedicine to target multidrug resistant tumors
Elise Lepeltier et al.
DRUG RESISTANCE UPDATES (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
Renlun Huang et al.
CELL DEATH & DISEASE (2020)
PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers
Jinling Yu et al.
NANOSCALE RESEARCH LETTERS (2020)
Dishevelled I -Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma
Wen-Ying Liao et al.
STEM CELL REPORTS (2020)
Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal
Ya-Xuan Zhu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
Ewa Gajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lipid/Hyaluronic Acid-Coated Doxorubicin-Fe3O4 as a Dual-Targeting Nanoparticle for Enhanced Cancer Therapy
Jinying Liang et al.
AAPS PHARMSCITECH (2020)
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
Duxin Sun et al.
ACS NANO (2020)
Hypoxia-responsive nanoparticles for tumor-targeted drug delivery
Yuce Li et al.
CANCER LETTERS (2020)
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinic et al.
DRUG RESISTANCE UPDATES (2020)
Role of Glutathione in Cancer: From Mechanisms to Therapies
Luke Kennedy et al.
BIOMOLECULES (2020)
Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization
Junhui Sui et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
Ujjwal Joshi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Differentiated cancer cell-originated lactate promotes the self-renewal of cancer stem cells in patient-derived colorectal cancer organoids
Hui Zhao et al.
CANCER LETTERS (2020)
A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer
Na Chang et al.
DRUG DELIVERY (2020)
DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells
Jianxi Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release
Ali Raza et al.
MOLECULES (2019)
Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance
Selma Maacha et al.
MOLECULAR CANCER (2019)
Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors
Isabelle M. S. Degors et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
Manoj Amrutkar et al.
BMC CANCER (2019)
Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles
Qing Yao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
The biochemical and molecular mechanisms involved in the role of tumor micro-environment stress in development of drug resistance
Lina Al-Akra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer
Xu Cheng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy
Li Wang et al.
NANO LETTERS (2019)
Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance
Mei Shao et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Proton Pump Inhibitors Modulate Transport Of Doxorubicin And Its Liposomal Form Into 2D And 3D Breast Cancer Cell Cultures
Migle Paskeviciute et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
Kyle R. Roell et al.
FRONTIERS IN GENETICS (2019)
Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin
Tooba Jabri et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance
Jia Liu et al.
BIOMATERIALS (2019)
Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells
Seounghun Kang et al.
NANOSCALE (2019)
Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors
Xiao Wei et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer
Jasmine Miller-Kleinhenz et al.
BIOMATERIALS (2018)
Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
Lei Zhou et al.
THERANOSTICS (2018)
Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance
Yating Xiao et al.
NANOSCALE (2018)
Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives
Hossam S. El-Sawy et al.
ACS NANO (2018)
Crosstalk in cancer resistance and metastasis
Saeed Norouzi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma
Xiyang Sun et al.
DRUG DELIVERY (2018)
Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
Zehua Liu et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Co-delivery strategies to overcome multidrug resistance in ovarian cancer
Ikram Ullah Khan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
pH, redox and photothermal tri-responsive DNA/polyethylenimine conjugated gold nanorods as nanocarriers for specific intracellular co-release of doxorubicin and chemosensitizer pyronaridine to combat multidrug resistant cancer
Yun Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
Jinglu Wang et al.
ONCOTARGET (2017)
Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics
Ranjith Kumar Kankala et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
The Use of Microfluidics in Cytotoxicity and Nanotoxicity Experiments
Scott C. McCormick et al.
MICROMACHINES (2017)
Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective
Zhenjie Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
Vanessa Lopes-Rodrigues et al.
SCIENTIFIC REPORTS (2017)
Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine
Jiao Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer
Fengqiao Li et al.
BIOMATERIALS (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
Agne Janoniene et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Near-Infrared Laser-Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer
Ranran Guo et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Maya Bar-Zeev et al.
DRUG RESISTANCE UPDATES (2017)
Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer
Fang Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective
Javed Ahmad et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models
Mariana S. Oliveira et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes
Rui Yang et al.
ONCOTARGET (2016)
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
Sten Friberg et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Michele Zanoni et al.
SCIENTIFIC REPORTS (2016)
TPGS2k/PLGA Nanoparticles for Overcoming Multidrug Resistance by Interfering Mitochondria of Human Alveolar Adenocarcinoma Cells
Dong-Fang Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles
Pengcheng Yu et al.
ACTA BIOMATERIALIA (2015)
Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
Feng Kong et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells
Qing Shi et al.
BIOMATERIALS (2015)
Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
Lei Jiang et al.
BIOMATERIALS (2015)
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk et al.
CANCER CELL INTERNATIONAL (2015)
Targeting autophagy to overcome drug resistance in cancer therapy
Ankit Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Targeting the DNA Damage Response in Cancer
Mark J. O'Connor
MOLECULAR CELL (2015)
Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers
Vasilios Tsouris et al.
BIOTECHNOLOGY ADVANCES (2014)
Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer
Viviana Castillo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Nanopreparations to overcome multidrug resistance in cancer
Niravkumar R. Patel et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Qi Yin et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Targeting the Bcl-2 family for cancer therapy
Shibu Thomas et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Identification of unique synergistic drug combinations associated with downexpression of survivin in a preclinical breast cancer model system
Daniel R. Budman et al.
ANTI-CANCER DRUGS (2012)
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Priyambada Parhi et al.
DRUG DISCOVERY TODAY (2012)
Modulation of Mitochondrial Permeability Transition Pore Affects Multidrug Resistance in Human Hepatocellular Carcinoma Cells
Xianlong Ling et al.
International Journal of Biological Sciences (2012)
MiR-122 in hepatic function and liver diseases
Jun Hu et al.
PROTEIN & CELL (2012)
Multidrug Resistance Gene (MDR-1) and Risk of Brain Metastasis in Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Koji Matsuo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Alternatives to animal testing: current status and future perspectives
Manfred Liebsch et al.
ARCHIVES OF TOXICOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy
Enza Lonardo et al.
CELL STEM CELL (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
Experimental considerations on the cytotoxicity of nanoparticles
Bokyung Kong et al.
NANOMEDICINE (2011)
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles
Eun Chul Cho et al.
NATURE NANOTECHNOLOGY (2011)
Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies
N. S. Wind et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2011)
Interactions of aluminum nanoparticles with human epidermal keratinocytes
Nancy A. Monteiro-Riviere et al.
JOURNAL OF APPLIED TOXICOLOGY (2010)
Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
Xiaowei Dong et al.
NANOMEDICINE (2010)
Signatures of mutation and selection in the cancer genome
Graham R. Bignell et al.
NATURE (2010)
Overcoming multidrug resistance (MDR) in cancer by nanotechnology
Bu HuiHui et al.
SCIENCE CHINA-CHEMISTRY (2010)
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
Maha Saad et al.
NANOMEDICINE (2008)
Systematic variation in gene expression patterns in human cancer cell lines
DT Ross et al.
NATURE GENETICS (2000)